<SEC-DOCUMENT>0001193125-21-042194-index.html : 20210216
<SEC-HEADER>0001193125-21-042194.hdr.sgml : 20210216
<ACCEPTANCE-DATETIME>20210212213059
ACCESSION NUMBER:		0001193125-21-042194
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20210216
DATE AS OF CHANGE:		20210212

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			4D Molecular Therapeutics Inc.
		CENTRAL INDEX KEY:			0001650648
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				473506994
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91921
		FILM NUMBER:		21631566

	BUSINESS ADDRESS:	
		STREET 1:		5858 HORTON STREET #455
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		5105052680

	MAIL ADDRESS:	
		STREET 1:		5858 HORTON STREET #455
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	4D Molecular Therapeutics Inc
		DATE OF NAME CHANGE:	20150811

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SCHAFFER DAVID
		CENTRAL INDEX KEY:			0001692929

	FILING VALUES:
		FORM TYPE:		SC 13G

	MAIL ADDRESS:	
		STREET 1:		19 RIMA COURT
		CITY:			DANVILLE
		STATE:			CA
		ZIP:			94526
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>d132203dsc13g.htm
<DESCRIPTION>SC 13G
<TEXT>
Document 1 - file: d132203dsc13g.htm

</DOCUMENT>
</SEC-DOCUMENT>